A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group Study
TOZER, R. G, BURDETTE-RADOUX, S, BERLANGER, K, DAVIS, M. L, LOHMANNS, R. C, RUSTHOVEN, J. R, WAINMAN, N, ZEE, B, SEYMOUR, L
Published in Investigational new drugs (01.11.2002)
Published in Investigational new drugs (01.11.2002)
Get full text
Journal Article